Gene Mutation Could Explain Humans’ High Risk of Heart Attack

Mutating a gene called CMAH in mice so it’s nonfunctional, as in humans, upped the animals’ chances of developing heart disease, a study finds.

Written byShawna Williams
| 2 min read
an illustration of the inside of a blood vessel with a buildup of plaque

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

ABOVE: © ISTOCK.COM, NAEBLYS

Between 2 million and 3 million years ago, humans lost the function of a gene called CMAH, one that remains active in other primates today. The mutation likely spread through our human ancestors because it has some benefit. For example, it’s thought to make humans better long-distance runners than our evolutionary cousins. But a new study in mice points to a significant downside: A far higher risk of heart attack.

Heart disease is the most common cause of death in the US, and atherosclerosis—the buildup of plaque on the inside of arteries—is frequently a component of that disease. Yet atherosclerosis isn’t a problem for other apes, even captive animals subject to some of the same risk factors as humans, such as high blood pressure and physical inactivity, Nissi Varki and Ajit Varki of the University of California, San Diego (UCSD), have found in previous work. “That’s ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Shawna was an editor at The Scientist from 2017 through 2022. She holds a bachelor’s degree in biochemistry from Colorado College and a graduate certificate in science communication from the University of California, Santa Cruz. Previously, she worked as a freelance editor and writer, and in the communications offices of several academic research institutions. As news director, Shawna assigned and edited news, opinion, and in-depth feature articles for the website on all aspects of the life sciences. She is based in central Washington State, and is a member of the Northwest Science Writers Association and the National Association of Science Writers.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies